1887

Abstract

Carbapenem-resistant pose an urgent threat to human health worldwide. sequence type (ST) 14, initially identified in the Middle East and South-Asia and co-harbouring the carbapenemase genes and is now emerging globally. One such strain was detected in the USA in 2013 from a patient initially treated in India that also carried , a 16S rRNA methyltransferase that confers resistance to all clinically relevant aminoglycosides. Genetic and phenotypic changes were observed in 14 serial isolates collected from this chronically infected patient. The index isolate carried five plasmids, including an IncFIB–IncHI1B (harbouring and ), an IncFIA ( ) and a ColE-like ( ), and was extensively resistant to antibiotics. Four years later, a subsequent isolate had accumulated 34 variants, including a loss-of-function mutation in , resulting in tigecycline non-susceptibility. Importantly, this isolate now only carried two plasmids, including a large mosaic molecule made of fragments, all harbouring distinct toxin–antitoxin systems, from three of the canonical plasmids. Of the original acquired antibiotic resistance genes, this isolate only retained , and as a result susceptibility to the carbapenems and amikacin was restored. Long-read sequencing of a subset of five representative isolates, collected between 2013 and 2017, allowed for the elucidation of the complex plasmid patterns and revealed the role of IS-mediated plasmid reshuffling in the evolution of this clone. Such investigations of the mechanisms underlying plasmid stability, together with global and local surveillance programmes, are key to a better understanding of plasmid host range and dissemination.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000892
2022-09-28
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/mgen/8/9/mgen000892.html?itemId=/content/journal/mgen/10.1099/mgen.0.000892&mimeType=html&fmt=ahah

References

  1. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399:629–655 [View Article]
    [Google Scholar]
  2. U.S. Department of Health and Human Services Antibiotic Resistance Threats in the United States Atlanta, GA: CDC; 2019 [View Article]
    [Google Scholar]
  3. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017; 8:460–469 [View Article]
    [Google Scholar]
  4. Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 2015; 59:5873–5884 [View Article]
    [Google Scholar]
  5. Shibl A, Al-Agamy M, Memish Z, Senok A, Khader SA et al. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 2013; 17:e1130–3 [View Article]
    [Google Scholar]
  6. Nagaraj G, Shamanna V, Govindan V, Rose S, Sravani D et al. High-resolution genomic profiling of carbapenem-resistant Klebsiella pneumoniae isolates: a multicentric retrospective indian study. Clin Infect Dis 2021; 73:S300–S307 [View Article]
    [Google Scholar]
  7. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in indian hospitals: report from the SENTRY antimicrobial surveillance program, 2006-2007. Antimicrob Agents Chemother 2011; 55:1274–1278 [View Article]
    [Google Scholar]
  8. Ben Nasr A, Decré D, Compain F, Genel N, Barguellil F et al. Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia. Antimicrob Agents Chemother 2013; 57:4089–4090 [View Article]
    [Google Scholar]
  9. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in sultanate of Oman. Clin Microbiol Infect 2012; 18:E144–8 [View Article]
    [Google Scholar]
  10. Doi Y. Treatment ptions for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis 2019; 69:S565–S575 [View Article]
    [Google Scholar]
  11. Lutgring JD, Zhu W, de Man TJB, Avillan JJ, Anderson KF et al. Phenotypic and genotypic characterization of Enterobacteriaceae producing oxacillinase-48-like carbapenemases, United States. Emerg Infect Dis 2018; 24:700–709 [View Article]
    [Google Scholar]
  12. Mouftah SF, Pál T, Higgins PG, Ghazawi A, Idaghdour Y et al. Diversity of carbapenem-resistant Klebsiella pneumoniae ST14 and emergence of a subgroup with KL64 capsular locus in the Arabian peninsula. Eur J Clin Microbiol Infect Dis 2021 [View Article]
    [Google Scholar]
  13. Doi Y, Hazen TH, Boitano M, Tsai Y-C, Clark TA et al. Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing. Antimicrob Agents Chemother 2014; 58:5947–5953 [View Article]
    [Google Scholar]
  14. Doi Y, O’Hara JA, Lando JF, Querry AM, Townsend BM et al. Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis 2014; 20:163–165 [View Article]
    [Google Scholar]
  15. Villa L, Poirel L, Nordmann P, Carta C, Carattoli A. Complete sequencing of an IncH plasmid carrying the blaNDM-1, blaCTX-M-15 and qnrB1 genes. J Antimicrob Chemother 2012; 67:1645–1650 [View Article] [PubMed]
    [Google Scholar]
  16. Acman M, Wang R, van Dorp L, Shaw LP, Wang Q et al. Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM. Nat Commun 2022; 13:1131 [View Article]
    [Google Scholar]
  17. David S, Cohen V, Reuter S, Sheppard AE, Giani T et al. Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2020; 117:25043–25054 [View Article]
    [Google Scholar]
  18. Martin MJ, Corey BW, Sannio F, Hall LR, MacDonald U et al. Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy. Proc Natl Acad Sci U S A 2021; 118:48 [View Article]
    [Google Scholar]
  19. Heiden SE, Hübner N-O, Bohnert JA, Heidecke C-D, Kramer A et al. A Klebsiella pneumoniae ST307 outbreak clone from germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition. Genome Med 2020; 12:113 [View Article]
    [Google Scholar]
  20. Stohr J, Verweij JJ, Buiting AGM, Rossen JWA, Kluytmans J. Within-patient plasmid dynamics in Klebsiella pneumoniae during an outbreak of a carbapenemase-producing Klebsiella pneumoniae. PLoS One 2020; 15:e0233313 [View Article]
    [Google Scholar]
  21. Simner PJ, Antar AAR, Hao S, Gurtowski J, Tamma PD et al. Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae. J Antimicrob Chemother 2018; 73:1796–1803 [View Article]
    [Google Scholar]
  22. Kim YJ, Kim S, Kim J, Bae S. Tracking short-term changes in the genetic diversity and antimicrobial resistance of OXA-232-producing Klebsiella pneumoniae ST14 in clinical settings. Clin Microbiol Infect 2020; 26:78–86 [View Article]
    [Google Scholar]
  23. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol 2010; 8:260–271 [View Article]
    [Google Scholar]
  24. Galac MR, Snesrud E, Lebreton F, Stam J, Julius M et al. A diverse panel of clinical acinetobacter baumannii for research and development. Antimicrob Agents Chemother 2020; 64:e00840-20 [View Article]
    [Google Scholar]
  25. Hunt M, Mather AE, Sánchez-Busó L, Page AJ, Parkhill J et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb Genom 2017; 3:e000131 [View Article] [PubMed]
    [Google Scholar]
  26. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 2014; 58:3895–3903 [View Article] [PubMed]
    [Google Scholar]
  27. Xie Y, Wei Y, Shen Y, Li X, Zhou H et al. TADB 2.0: an updated database of bacterial type II toxin-antitoxin loci. Nucleic Acids Res 2018; 46:D749–D753 [View Article]
    [Google Scholar]
  28. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 2006; 34:D32–6 [View Article]
    [Google Scholar]
  29. He S, Hickman AB, Varani AM, Siguier P, Chandler M et al. Insertion sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition. mBio 2015; 6:e00762 [View Article]
    [Google Scholar]
  30. Jousset AB, Bonnin RA, Rosinski-Chupin I, Girlich D, Cuzon G et al. A 4.5-year within-patient evolution of a colistin-resistant Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258. Clin Infect Dis 2018; 67:1388–1394 [View Article]
    [Google Scholar]
  31. Nang SC, Morris FC, McDonald MJ, Han M-L, Wang J et al. Fitness cost of mcr-1-mediated polymyxin resistance in Klebsiella pneumoniae. J Antimicrob Chemother 2018; 73:1604–1610 [View Article]
    [Google Scholar]
  32. Liu P, Chen S, Wu Z-Y, Qi M, Li X-Y et al. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist 2020; 22:238–243 [View Article]
    [Google Scholar]
  33. San Millan A, MacLean RC. Fitness costs of plasmids: a limit to plasmid transmission. Microbiol Spectr 2017; 5: [View Article]
    [Google Scholar]
  34. Huang T-W, Chen T-L, Chen Y-T, Lauderdale T-L, Liao T-L et al. Copy number change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate. PLoS One 2013; 8:e62774 [View Article]
    [Google Scholar]
  35. Porse A, Schønning K, Munck C, Sommer MOA. Survival and evolution of a large multidrug resistance plasmid in new clinical bacterial hosts. Mol Biol Evol 2016; 33:2860–2873 [View Article]
    [Google Scholar]
  36. Chmelnitsky I, Shklyar M, Leavitt A, Sadovsky E, Navon-Venezia S et al. Mix and match of KPC-2 encoding plasmids in Enterobacteriaceae-comparative genomics. Diagn Microbiol Infect Dis 2014; 79:255–260 [View Article]
    [Google Scholar]
  37. Conlan S, Park M, Deming C, Thomas PJ, Young AC et al. Plasmid dynamics in KPC-positive Klebsiella pneumoniae during long-term patient colonization. mBio 2016; 7:e00742-16 [View Article]
    [Google Scholar]
  38. Carroll AC, Wong A. Plasmid persistence: costs, benefits, and the plasmid paradox. Can J Microbiol 2018; 64:293–304 [View Article]
    [Google Scholar]
  39. Harrison E, Brockhurst MA. Plasmid-mediated horizontal gene transfer is a coevolutionary process. Trends Microbiol 2012; 20:262–267 [View Article]
    [Google Scholar]
  40. Lee H, Shin J, Chung Y-J, Park M, Kang KJ et al. Co-introduction of plasmids harbouring the carbapenemase genes, blaNDM-1 and blaOXA-232, increases fitness and virulence of bacterial host. J Biomed Sci 2020; 27:8 [View Article]
    [Google Scholar]
  41. San Millan A, Peña-Miller R, Toll-Riera M, Halbert ZV, McLean AR et al. Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nat Commun 2014; 5:5208 [View Article]
    [Google Scholar]
  42. Ogura T, Hiraga S. Mini-F plasmid genes that couple host cell division to plasmid proliferation. Proc Natl Acad Sci 1983; 80:4784–4788 [View Article]
    [Google Scholar]
  43. Díaz-Orejas R, Espinosa M, Yeo CC. The importance of the expendable: toxin-antitoxin genes in plasmids and chromosomes. Front Microbiol 2017; 8:1479 [View Article]
    [Google Scholar]
  44. Liu Y, Gao Z, Liu G, Geng Z, Dong Y et al. Structural insights Into the transcriptional regulation of higBA toxin-antitoxin system by antitoxin higA in Pseudomonas aeruginosa. Front Microbiol 2019; 10:3158 [View Article]
    [Google Scholar]
  45. Varani A, He S, Siguier P, Ross K, Chandler M. The IS6 family, a clinically important group of insertion sequences including IS26. Mob DNA 2021; 12:11 [View Article]
    [Google Scholar]
  46. Harmer CJ, Moran RA, Hall RM, Bush K. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 2014; 5:e01801–14 [View Article]
    [Google Scholar]
  47. Harmer CJ, Hall RM. IS26-mediated precise excision of the IS26-aphA1a translocatable unit. mBio 2015; 6:e01866–15 [View Article]
    [Google Scholar]
  48. Weber RE, Pietsch M, Frühauf A, Pfeifer Y, Martin M et al. IS26-mediated transfer of blaNDM–1 as the main route of resistance transmission during a polyclonal, multispecies outbreak in a German hospital. Front Microbiol 2019; 10:2817 [View Article]
    [Google Scholar]
  49. Hall JPJ, Wright RCT, Harrison E, Muddiman KJ, Wood AJ et al. Plasmid fitness costs are caused by specific genetic conflicts enabling resolution by compensatory mutation. PLoS Biol 2021; 19:e3001225 [View Article]
    [Google Scholar]
  50. Stoesser N, Sheppard AE, Moore CE, Golubchik T, Parry CM et al. Extensive Within-Host Diversity in Fecally Carried Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates: Implications for Transmission Analyses. J Clin Microbiol 2014; 53:2122–2131 [View Article] [PubMed]
    [Google Scholar]
  51. Yoon EJ, Oh Y, Jeong SH. Development of tigecycline resistance in arbapenemase-Producing Klebsiella pneumoniae Sequence Type 147 via AcrAB Overproduction Mediated by Replacement of the ramA Promoter. Ann Lab Med 2020; 40:15–20 [View Article]
    [Google Scholar]
  52. Fang L, Chen Q, Shi K, Li X, Shi Q et al. Step-wise increase in tigecycline resistance in Klebsiella pneumoniae associated with mutations in ramR, lon and rpsJ. PLoS One 2016; 11:e0165019 [View Article]
    [Google Scholar]
  53. Chung The H, Karkey A, Pham Thanh D, Boinett CJ, Cain AK et al. A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae. EMBO Mol Med 2015; 7:227–239 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000892
Loading
/content/journal/mgen/10.1099/mgen.0.000892
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error